<i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.

Selle K, Fletcher JR, Tuson H, Schmitt DS, McMillan L, Vridhambal GS, Rivera AJ, Montgomery SA, Fortier LC, Barrangou R, Theriot CM, Ousterout DG.

Open source

DOI: 10.1128/mbio.00019-20
Published: 2020-03-10
Container: mBio
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/mbio.00019-20,
  title = {<i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.},
  author = {Selle K and  Fletcher JR and  Tuson H and  Schmitt DS and  McMillan L and  Vridhambal GS and  Rivera AJ and  Montgomery SA and  Fortier LC and  Barrangou R and  Theriot CM and  Ousterout DG.},
  year = {2020},
  journal = {mBio},
  doi = {10.1128/mbio.00019-20},
  url = {https://doi.org/10.1128/mbio.00019-20}
}

RIS

TY  - JOUR
TI  - <i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.
AU  - Selle K
AU  -  Fletcher JR
AU  -  Tuson H
AU  -  Schmitt DS
AU  -  McMillan L
AU  -  Vridhambal GS
AU  -  Rivera AJ
AU  -  Montgomery SA
AU  -  Fortier LC
AU  -  Barrangou R
AU  -  Theriot CM
AU  -  Ousterout DG.
PY  - 2020
JO  - mBio
DO  - 10.1128/mbio.00019-20
UR  - https://doi.org/10.1128/mbio.00019-20
ER  -

APA

K, S., JR, F., H, T., DS, S., L, M., GS, V., AJ, R., SA, M., LC, F., R, B., CM, T., & DG., O. (2020). <i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.. mBio. https://doi.org/10.1128/mbio.00019-20

Source records

europe-pmc · retrieved 2026-09-25T22:44:01.389Z
doaj · retrieved 2026-09-25T22:44:01.391Z